FDA Approved: QUETIAPINE EXTENDED RELEASE — Supplemental Application (ACI Healthcare USA, Inc.)

View source ↗

Summary

FDA approves a supplemental application for a generic quetiapine extended-release product by ACI Healthcare USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• Quetiapine Extended-Release (quetiapine extended-release)

Snippet

SUPPL AP for QUETIAPINE EXTENDED RELEASE (QUETIAPINE)